Current Opinion in Biotechnology (COBIOT) publishes authoritative, comprehensive, and systematic reviews. COBIOT helps specialists keep up to date with a clear and readable synthesis on current advances biotechnology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance. 

Current Opinion in Biotechnology is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Biotechnology (CRBIOT). CO+RE journals leverage the Current Opinion legacy?of editorial excellence, high-impact, and global reach?to ensure they are a widely read resource that is integral to scientists? workflow. 

Current Opinion in Biotechnology is divided into themed sections, each of which is reviewed once a year. Themes include analytical biotechnology; plant biotechnology; food biotechnology; energy biotechnology; environmental biotechnology; systems biology; nanobiotechnology; tissue, cell and pathway engineering; chemical biotechnology; and pharmaceutical biotechnology. 

The journal builds on Elsevier?s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.
Expertise ? Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant.
Comprehensiveness ? There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry.
Impact ? In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores.


Selection of topics to be reviewed 
Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. 

Reviews
Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year. 

Review articles in Current Opinion in Biotechnology are by invitation only. 

Editorial Overview
Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments. 

Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. 

Editor-in-Chief
Greg Stephanopoulos
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
Jan Roelof van der Meer
University of Lausanne, Lausanne, Switzerland
Editorial Board
Lilia Alberghina
University of Milan–Bicocca, Milano, Italy
Maciek Antoniewicz
University of Delaware, Newark, Delaware, United States
Edward Bayer
Weizmann Institute of Science Department of Biomolecular Sciences, Rehovot, Israel
George Guo-Qiang Chen
Tsinghua University, Beijing, China
Nam-Hai Chua
The Rockefeller University Plant Molecular Biology Laboratory, New York, New York, United States
Jiri Damborsky
Masaryk University, Brno, Czech Republic
Julian Davies
The University of British Columbia Department of Microbiology & Immunology, Vancouver, British Columbia, Canada
Luis Angel Fernandez
Spanish Scientific Research Council, Madrid, Spain
Alain Filloux
Imperial College London, London, United Kingdom
Matthias Heinemann
University of Groningen, Groningen, The Netherlands
Karsten Hiller
Braunschweig University of Technology, Braunschweig, Germany
Lee Hood
Institute for Systems Biology, Seattle, Washington, United States
Karl-Erich Jaeger
Heinrich Heine University Düsseldorf Department of Molecular Enzymtechnology, Jülich, Germany
Janet Jansson
E O Lawrence Berkeley National Laboratory, Berkeley, California, United States
Mattheos Koffas
Rensselaer Polytechnic Institute, Troy, New York, United States
Kazuhiro Kogure
The University of Tokyo Atmosphere and Ocean Research Institute, Nakano-Ku, Japan
Sang Yup Lee
Korea Advanced Institute of Science and Technology Department of Chemical and Biomolecular Engineering, Daejeon, Korea, Republic of
Marcial L. Lizarraga-Partida
CICESE, Biotecnologia Mariana, San Diego, California, United States
Victor de Lorenzo
Spanish Scientific Research Council, Madrid, Spain
Joachim Messing †
Waksman Institute of Microbiology, Piscataway, New Jersey, United States
Beat Mollet
Nestle Research Center, Lausanne 26, Switzerland
Elke Nevoigt
Jacobs University Bremen gGmbH, Bremen, Germany
Robin Offord
Mintaka Foundation for Medical Research, Plan Les Ouates, Switzerland
Sven Panke
Swiss Federal Institute of Technology Department of Biosystems Science and Engineering, Basel, Switzerland
Carla Pruzzo
University of Genoa, Genova, Italy
Juan Ramos
Del Zaidin Experimental Station, Granada, Spain
Eugene Rosenberg
Tel Aviv University, Tel Aviv, Israel
Ian Rowland
University of Reading, Reading, United Kingdom
Athanassios Sambanis
Georgia Institute of Technology, Atlanta, Georgia, United States
Ka-Yiu San
Rice University, Houston, Texas, United States
Jacqueline Shanks
Iowa State University, Ames, Iowa, United States
Allan Shatzman
GlaxoSmithKline USA, King of Prussia, Pennsylvania, United States
Willem de Vos
Wageningen University, Wageningen, Netherlands
Daniel Wang
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
Wilfried Weber
University of Freiburg, Freiburg im Breisgau, Germany